![[Dehydro-Pro4] Substance P (4-11)](https://file.medchemexpress.com/product_pic/hy-p3820.gif "Click to View [Dehydro-Pro4] Substance P (4-11) Product Detail")
Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
20 Results for "
7-dehydrocholesterol
" in MedChemExpress (MCE) Product Catalog:
Products (20)
20 Results for "7-dehydrocholesterol" in MCE Product Catalog:
8
Category:
Human Gut Microbiota Metabolites Other Diseases Endogenous metabolite Disease Research Fields Steroids
Target:
1
1 Cited Publications
Cat. No.: HY-164561
CAS No.: 1678515-93-9
Research Areas:
TASIN-30 is a selective EBP inhibitor with an EC50 of 0.097 μM. TASIN-30 blocks the production of 7-dehydrocholesterol (7-DHC) and downstream cholesterol biosynthesis processes. TASIN-30 depletes downstream sterols, disrupts the integrity of lipid rafts in tumor cells, accelerates intracellular cholesterol consumption, and inhibits tumor cell proliferation. TASIN-30 induces ferroptosis and apoptosis by reducing 7-DHC levels and increasing phospholipid peroxidation. TASIN-30 achieves tumor suppression in nude mice with osteosarcoma. TASIN-30 can be used in cancer-related research such as colorectal cancer and osteosarcoma .
Target:
Research Areas:
Target:
Cat. No.: HY-113279S
CAS No.: 388622-58-0
Cat. No.: HY-113279R
CAS No.: 434-16-2
Target:
Research Areas:
BM 15766 sulfate is an inhibitor of 7-dehydrocholesterol δ7-reductase and reduces plasma cholesterol levels. BM 15766 sulfate is a hypolipidemic agent .
Target:
Research Areas:
Previtamin D3 is an orally active, thermolabile steroidal compound that generates vitamin D3, as well as biologically inactive lumisterol and tachysterol. Previtamin D3 is synthesized in the skin of humans and rats via the UV-B-mediated photoconversion of 7-dehydrocholesterol. Previtamin D3 lacks direct anti-rachitic activity, and its in vivo activity relies on the vitamin D3 it produces. Previtamin D3 can be used in studies related to rickets and vitamin D metabolism .
Cat. No.: HY-142129
CAS No.: 10346-43-7
Target:
Research Areas:
Pyrocholecalciferol, a vitamin D analogue, produced by photochemical transformation of 7-dehydrocholesterol (7-DHC) .
Cat. No.: HY-E71997
Target:
Research Areas:
7-Dehydrocholesterol reductase (EC 1.3.1.21) is an oxidoreductase that can convert cholesterol and NADP + into 7-dehydrocholesterol, NADPH and H +.
Cat. No.: HY-P3820
Target:
Research Areas:
Cat. No.: HY-P2424
CAS No.: 144396-38-3
Synonyms: CCK-J
Target:
Research Areas:
Cat. No.: HY-W726633
CAS No.: 10355-14-3
Target:
Research Areas:
Metabolic Disease Inflammation/Immunology Endocrinology Cancer
Boxidine is an orally active DHCR7 inhibitor. Boxidine inhibits DHCR7, blocks the conversion of 7-Dehydrocholesterol (HY-113279) to Cholesterol (HY-N0322), reduces serum cholesterol levels, causes accumulation of 7-dehydrocholesterol in serum and tissues, and inhibits sterol absorption. Boxidine exhibits antiproliferative and anticancer activities, with marginal activity against mouse tumors. Boxidine can be used in research related to diseases such as tumors and adrenal cancer .
Cat. No.: HY-P10872
Cat. No.: HY-P10906
CAS No.: 2868285-05-4
Target:
Research Areas:
Cat. No.: HY-P11455
Cat. No.: HY-P11766
Synonyms: GALA-cholesterol
Target:
Research Areas:
GALA-chol is a cholesterol-conjugated pH-responsive fusion peptide that can serve as a delivery adjuvant. GALA-chol enhances the endocytosis of siRNA RET/PTC1-SQ nanoparticles, inhibits cell viability, and undergoes pH-responsive charge conversion in the acidic lysosomal environment, thereby promoting lysosomal escape of small extracellular vesicle (sEV) cargo. GALA-chol anchors to the sEV membrane and maintains the structural integrity and intrinsic homing activity of sEVs. GALA-chol can be used in studies related to adjuvant delivery .
Cat. No.: HY-P11766A
Synonyms: GALA-cholesterol TFA
Target:
Research Areas:
GALA-chol TFA (GALA-cholesterol TFA) is a cholesterol-conjugated pH-responsive fusion peptide that can serve as a delivery adjuvant. GALA-chol TFA enhances the endocytosis of siRNA RET/PTC1-SQ nanoparticles, inhibits cell viability, and undergoes pH-responsive charge conversion in the acidic lysosomal environment, thereby promoting lysosomal escape of small extracellular vesicle (sEV) cargo. GALA-chol TFA anchors to the sEV membrane and maintains the structural integrity and intrinsic homing activity of sEVs. GALA-chol TFA can be used in studies related to adjuvant delivery .
Cat. No.: HY-P702263
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: DHCR7; Delta-7-dehydrocholesterol Reductase; Prev. SLOS; Delta(14)-Sterol Reductase TM7SF2; Cholesterol-5,6-Epoxide Hydrolase Subunit DHCR7; Putative Sterol Reductase SR-2; Sterol Delta(7)-Reductase; Smith-Lemli-Opitz Syndrome; Delta7-Sterol Reductase; St
Species:
Source:
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
